Hu Lei, Lin Chao, Li Renfu, Xu Shouying, Xu Qiang, An Zihao, Tang Chao
National Clinical Research Center for Child Health of Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, China.
SICU, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, China.
Neuromolecular Med. 2025 Apr 27;27(1):29. doi: 10.1007/s12017-025-08854-0.
Deregulated reactive oxygen species (ROS) levels trigger oxidative stress (OS) injury that is closely associated with the pathophysiology of various neurological disorders. Therefore, therapeutic efforts at oxidative events in the pathway of neuronal degeneration would be promisingly helpful for intervention and treatment of related diseases. Here, we report that gastrodin, the main bioactive constituent of Rhizoma Gastrodiae, protects the mouse hippocampal HT22 cells from OS caused by hydrogen peroxide (HO), including the increased cell viability, elevated Glutathione (GSH) levels, decreased Malondialdehyde (MDA) activity, and down-regulated ROS levels with restored cell morphology. Through RNA-sequencing (RNA-Seq) and multiple experiments, we screened the gene Mamdc2 that could be a potential regulating target of gastrodin. Mechanistically, gastrodin exerts its protective effects on neuronal cells from oxidative injury by suppressing miRNA-125b-5p, which increases its target Mamdc2 expression. Overexpression of miR-125b-5p mimics significantly attenuates the gastrodin-triggered protective effects against HO in HT22 cells, including the decreased cell viability, down-regulated GSH activity, increased MDA activity, and up-regulated ROS production, compared to the gastrodin-administration with control miRNA group. However, these results could be effectively restored by the ectopic expression of Mamdc2, leading to the opposite outcomes to those of miR-125b-5p mimics-overexpression. Thus, the current study provides evidence that gastrodin has the potential for intervention and therapy of OS injury-associated neurological diseases in future.
活性氧(ROS)水平失调会引发氧化应激(OS)损伤,这与多种神经疾病的病理生理学密切相关。因此,针对神经元变性途径中的氧化事件进行治疗,有望对相关疾病的干预和治疗有所帮助。在此,我们报告天麻的主要生物活性成分天麻素可保护小鼠海马HT22细胞免受过氧化氢(H₂O₂)引起的氧化应激,包括提高细胞活力、升高谷胱甘肽(GSH)水平、降低丙二醛(MDA)活性、下调ROS水平以及恢复细胞形态。通过RNA测序(RNA-Seq)和多项实验,我们筛选出可能是天麻素潜在调控靶点的基因Mamdc2。机制上,天麻素通过抑制miRNA-125b-5p对神经元细胞发挥抗氧化损伤保护作用,miRNA-125b-5p的抑制增加了其靶标Mamdc2的表达。与用对照miRNA处理的天麻素给药组相比,miR-125b-5p模拟物的过表达显著减弱了天麻素对HT22细胞中H₂O₂触发的保护作用,包括细胞活力降低、GSH活性下调、MDA活性增加和ROS产生上调。然而,Mamdc2的异位表达可有效恢复这些结果,导致与miR-125b-5p模拟物过表达相反的结果。因此,本研究为天麻素未来干预和治疗氧化应激损伤相关神经疾病提供了证据。